A double-blind comparison of the efficacy and tolerability of telmisartan 40-80 mg vs. losartan 50-100 mg in Taiwanese hypertensive patients

International Journal of Clinical Practice, Supplement

Volumn , Issue 145, 2004, Pages 40-45

  Lee, Yuan Teh ^a   Lee, C M ^a   Lin, C S ^b   Sheu, S H ^c   Kuo, W K ^d   Tsai, C W ^e   Huang, L C ^f   Huang, H C ^g   Wang, J S ^h   Tseng, W K ⁱ  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d Taipei Municipal Chung Hsin Hospital   (Taiwan)

^e EN CHU KONG HOSPITAL   (Taiwan)

^f TAIPEI CITY HOSPITAL   (Taiwan)

^g Section of Infectious Diseases   (Taiwan)

^h JEN AI HOSPITAL   (Taiwan)

ⁱ CHENG CHING GENERAL HOSPITAL   (Taiwan)

Author keywords

Angiotensin II receptor blocker; Antihypertensives; Hypertension; Losartan; Telmisartan

Indexed keywords

AMLODIPINE; ATENOLOL; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LISINOPRIL; LOSARTAN; PLACEBO; SUBSTANCE P; TELMISARTAN; VALSARTAN;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SACCHAROMYCES; SIDE EFFECT; SODIUM RETENTION; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; WATER RETENTION;

ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; LOSARTAN; MALE; MIDDLE AGED; PATIENT COMPLIANCE;

EID: 10344262020     PISSN: 1368504X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Nicholls MG, Charles CJ, Crozier IG, et al. Blockade of the renin-agiotensin system. J Hypertens 1994; 12 (Suppl. 10): S95-S103.
2. Unger T. Blood pressure-lowering and renin-angiotensin system blockade. J Hypertens 2003; 21 (Suppl. 6): S3-S7.
3. Just PM. The positive association of cough with angiotensin-converting enzyme inhibitors. Pharmacotherapy 1989; 9: 82-7.
4. Burnier M, Brunner HR, Angiotensin II receptor antagonists. Lancet 2000; 355: 637-45.
5. Tseng WP. Epidemiology of hypertension among Chinese in Taiwan. J Hum Hypertens 1990; 4: 144-6.
6. Lien WP, Lai LP, Chen JJ, et al. A retrospective hospital-based study of coronary risk factors in Taiwan. Analysis of patients with established diagnoses. Jpn Heart J 1998; 39: 435-44.
7. Gao M, Ikeda K, Hattori H, et al. Cardiovascular risk factors emerging in Chinese populations undergoing urbanization. Hypertens Res 1999; 22: 209-15.
8. Singh RB, Suh IL, Singh VP, et al. Hypertension and stroke in Asia: prevalence, control and strategies in developing countries for prevention. J Hum Hypertens 2000; 14: 749-63.
9. Chiu HC, Lee TK, Mau LW, et al. Prevalence of cardiovascular risk factors of elderly persons in Taiwan. Kaohsiung J Med Sci 2002; 18: 53-61.
10. Pan WH, Chang HY, Yeh WT, et al. Prevalence, awareness, treatment and control of hypertension in Taiwan: results of Nutrition and Health Survey In Taiwan (NAHSIT) 1993-96. J Hum Hypertens 2001; 15: 793-8.
11. Woo KS, Nicholls MG. High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese. Br J Clin Pharmacol 1995; 40: 141-4.
12. Lee YJ, Tsai JC. Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor -58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus. Metabolism 2001; 50: 1346-50.
13. Sharpe M, Jarvis B, Goa KL. Telmisartan. A review of its use in hypertension. Drugs 2001; 61: 1501-29.
14. Lacourcière Y, the Telmisartan Cough Study Group. The incidence of cough: a comparison of lisinopril, placebo and telmisartan, a novel angiotensin II antagonist. Int J Clin Pract 1999; 53: 99-103.
15. Henderson SO, Bretsky P, DeQuattro V, et al. Treatment of hypertension in African Americans and Latinos: the effect of JNC VI on urban prescribing practices. J Clin Hypertens 2003; 5: 107-12.
16. Lu Y-H, Hwang Y-S. Losartan monotherapy in systemic hypertension - an open-label uncontrolled trial. Acta Cardiol Sin 2002; 18: 167-72.
17. Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure asa predictor of silent and clinical cerebrovascular disease in elderly hypertensives: prospective study. Circulation 2003; 107: 1401-6.
18. Shimada K, Kario K, Umeda Y, et al. Early morning surge in blood pressure. Blood Press Monit 2001; 6: 349-53.
19. Smith DH, Cramer MJ, Neutel JM, et al. Comparison of telmisartan versus losartan meta-analysis of titration-to-response studies. Blood Press Monit 2003; 8: 111-7.